Dewpoint Therapeutics

Last updated: May 01, 2024

CEO Amir Nashat
CEO Amir Nashat
Country: USA | Funding: $287M (+)

Website: http://www.dewpointtherapeutics.com

Dewpoint Therapeutics is a biotech company which develop a drug platform that targets biomolecular condensates.